Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28678170)

Published in Int J Mol Sci on July 05, 2017

Authors

Evangelia A Koutsogiannouli1, Nicholas Wagner2, Christiane Hader3, Maria Pinkerneil4, Michèle J Hoffmann5, Wolfgang A Schulz6

Author Affiliations

1: Department of Urology, Heinrich Heine University, 40225 Düsseldorf, Germany. evkouts@gmail.com.
2: Department of Urology, Heinrich Heine University, 40225 Düsseldorf, Germany. nicholas.wagner@hhu.de.
3: Department of Urology, Heinrich Heine University, 40225 Düsseldorf, Germany. christiane.hader@hhu.de.
4: Department of Urology, Heinrich Heine University, 40225 Düsseldorf, Germany. maria.lehmann@hhu.de.
5: Department of Urology, Heinrich Heine University, 40225 Düsseldorf, Germany. michele.hoffmann@hhu.de.
6: Department of Urology, Heinrich Heine University, 40225 Düsseldorf, Germany. wolfgang.schulz@hhu.de.

Articles cited by this

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98

COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res (2014) 10.77

Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73

Cancer Statistics, 2017. CA Cancer J Clin (2017) 4.77

Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene (2007) 2.85

Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein. J Biol Chem (2008) 2.19

STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. Mol Cell Biol (2007) 1.78

The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia. Blood (2014) 1.75

Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol (2007) 1.70

ARID1B is a specific vulnerability in ARID1A-mutant cancers. Nat Med (2014) 1.66

HAT4, a Golgi apparatus-anchored B-type histone acetyltransferase, acetylates free histone H4 and facilitates chromatin assembly. Mol Cell (2011) 1.59

Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression. Cancer Discov (2015) 1.44

TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc Natl Acad Sci U S A (2007) 1.39

Bladder cancer. Lancet (2016) 1.25

The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Cell Cycle (2012) 1.24

Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res (2003) 1.21

MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem (2002) 1.20

Understanding urothelial carcinoma through cancer pathways. Int J Cancer (2006) 1.17

Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression. J Biol Chem (2013) 1.06

GCN5: a supervisor in all-inclusive control of vertebrate cell cycle progression through transcription regulation of various cell cycle-related genes. Gene (2005) 1.03

MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation. J Biol Chem (2004) 1.01

Histone acetyltransferase PCAF is required for Hedgehog-Gli-dependent transcription and cancer cell proliferation. Cancer Res (2013) 0.95

Histone acetyltransferase PCAF up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling. Mol Cancer (2013) 0.91

The Histone Acetyltransferase GCN5 Expression Is Elevated and Regulated by c-Myc and E2F1 Transcription Factors in Human Colon Cancer. Gene Expr (2015) 0.85

Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma. Cell Death Dis (2015) 0.84

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo. Oncogenesis (2015) 0.84

Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms. Mol Cancer Ther (2016) 0.84

KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases. J Med Chem (2016) 0.82

GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways. Int J Mol Sci (2015) 0.80

PCAF-mediated Akt1 acetylation enhances the proliferation of human glioblastoma cells. Tumour Biol (2014) 0.80

MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits. Biochim Biophys Acta (2014) 0.79

Epigenetic Modulation using Small Molecules - Targeting Histone Acetyltransferases in Disease. Curr Med Chem (2017) 0.78

PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6. Nucleic Acids Res (2016) 0.78

Molecular mechanisms in urinary bladder carcinogenesis. J BUON (2012) 0.77

PCAF acts as a gastric cancer suppressor through a novel PCAF-p16-CDK4 axis. Am J Cancer Res (2016) 0.75

Histone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expression. Cell Biosci (2016) 0.75

Articles by these authors

Epigenetics of Urological Cancers. Int J Mol Sci (2019) 0.75